COMBIMIST L RESPICAPS.

Description

COMBIMIST L RESPICAPS combine Formoterol Fumarate, a long-acting beta-2 agonist (LABA), and Levosalbutamol Sulphate, a short-acting beta-2 agonist (SABA), in a dry powder inhalation capsule designed for respiratory relief in patients with asthma and chronic obstructive pulmonary disease (COPD).

Formoterol provides prolonged bronchodilation by relaxing airway muscles, improving airflow for up to 12 hours. Levosalbutamol offers quick relief from acute bronchospasm by rapidly dilating the airways. Together, they offer both immediate and sustained symptom control.

Key Benefits:

• Combines rapid and long-acting bronchodilation

• Provides quick relief and prolonged control of bronchospasm

• Suitable for asthma and COPD management

• Easy-to-use RESPICAPS for dry powder inhalation

Indications:

• Bronchospasm relief in asthma

• Chronic obstructive pulmonary disease (COPD) management

Dosage:
Use as prescribed, typically inhaling one capsule twice daily via dry powder inhaler.

Precautions:
Not for acute severe asthma attacks. Use under medical supervision. Possible side effects include tremors, headache, and palpitations.